P-Xylene

P-Xylene

SCHEMBL235089

COC.Cc1ccc(C)cc1.OCCO

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 5/20 0.50
TDP1 Q9NUW8 2/20 0.50
GAA P10253 1/20 0.42
AGXT P21549 2/20 0.40
ALDH1A1 P00352 3/20 0.39
LMNA P02545 2/20 0.39
CA2 P00918 2/20 0.39
IDO1 P14902 1/20 0.39
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
LPL P06858 1/20 0.39
LIPG Q9Y5X9 1/20 0.39
ORAI1 Q96D31 1/20 0.39
ORAI2 Q96SN7 1/20 0.39
ORAI3 Q9BRQ5 1/20 0.39
TRPV6 Q9H1D0 1/20 0.39
MMP13 P45452 1/20 0.38
CA1 P00915 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
P-Xylene SCHEMBL109385 0.90 ACHE (0.61) ACHETDP1GAAALDH1A1LMNA
P-Xylene SCHEMBL28856424 0.90 ACHE (0.61) ACHETDP1GAAALDH1A1LMNA
P-Xylene SCHEMBL4762911 0.87 ACHE (0.57) ACHETDP1GAAALDH1A1LMNA
P-Xylene SCHEMBL4858832 0.83 ACHE (0.73) ACHETDP1AGXTALDH1A1LMNA
Ethylene Glycol SCHEMBL27592942 0.80 TEAD4 (0.58) ACHETDP1ALDH1A1LMNAMMP13
P-Xylene SCHEMBL3688331 0.80 GAA (0.43) ACHETDP1GAAALDH1A1LMNA
Ethylene Glycol SCHEMBL1237729 0.80 ALDH1A1 (0.47) TDP1GAAALDH1A1LMNACA2
M-Xylene SCHEMBL7784481 0.78 ACHE (0.60) ACHEGAAALDH1A1LMNAIDO1
P-Xylene SCHEMBL8994094 0.78 GAA (0.41) ACHETDP1GAAALDH1A1LMNA
P-Xylene SCHEMBL4079357 0.78 ACHE (0.53) ACHETDP1GAAALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12312300-B2 Process for recovering close boiling products LANZATECH, INC. (US) 2025-05-27 US claimed
EP-4416297-A1 FLEXIBLE PRODUCT SEPARATION AND RECOVERY Lanzatech, Inc. (US) 2024-08-21 EP claimed
US-20240059628-A1 PROCESS FOR RECOVERING CLOSE BOILING PRODUCTS LANZATECH, INC. 2024-02-22 US claimed
WO-2023064695-A1 FLEXIBLE PRODUCT SEPARATION AND RECOVERY LANZATECH, INC. (US) 2023-04-20 WO claimed
US-20230113411-A1 FLEXIBLE PRODUCT SEPARATION AND RECOVERY LANZATECH, INC. 2023-04-13 US claimed
EP-3921433-A1 PROCESS FOR RECOVERING CLOSE BOILING PRODUCTS Lanzatech, Inc. (US) 2021-12-15 EP claimed
US-11091415-B2 Process for recovering close boiling products LANZATECH, INC. (US) 2021-08-17 US claimed
CN-112969795-A Process for recovering close boiling products 朗泽科技有限公司 2021-06-15 CN claimed
US-10927270-B2 Oil-based ink composition for writing instruments, and writing instrument, marking pen and ballpoint pen comprising the same KABUSHIKI KAISHA PILOT CORPORATION (JP) 2021-02-23 US claimed
US-20200255362-A1 PROCESS FOR RECOVERING CLOSE BOILING PRODUCTS LANZATECH PRIVATE LIMITED 2020-08-13 US claimed
WO-2020163020-A1 PROCESS FOR RECOVERING CLOSE BOILING PRODUCTS LANZATECH, INC. (US) 2020-08-13 WO claimed
US-5445716-A With stable and reusable extractive agent which improves relative volatility difference Berg, Lloyd (US) 1995-08-29 US claimed
JP-9176263-A None JP disclosed
JP-8239559-A None JP disclosed
US-12312300-B2 Process for recovering close boiling products LANZATECH, INC. (US) 2025-05-27 US disclosed
EP-4416297-A1 FLEXIBLE PRODUCT SEPARATION AND RECOVERY Lanzatech, Inc. (US) 2024-08-21 EP disclosed
EP-0838537-A1 METAL SURFACE TREATMENTS, METHOD FOR TREATING METAL SURFACE, AND SURFACE-TREATED METALLIC MATERIAL NIPPON PAINT CO., LTD. (JP) 1998-04-29 EP disclosed
JP-H09176263-A PHENOLIC RESIN COMPOSITION SUMITOMO DUREZ CO LTD 1997-07-08 JP disclosed
JP-H08239559-A RESIN COMPOSITION FOR FRICTION MATERIAL SUMITOMO DUREZ CO LTD 1996-09-17 JP disclosed
US-5445716-A With stable and reusable extractive agent which improves relative volatility difference Berg, Lloyd (US) 1995-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10927270-B2 Oil-based ink composition for writing instruments, and writing instrument, marking pen and ballpoint pen comprising the same MKI67, JAK2, BRPF3 ACHE 3160/4885TDP1 1682/4885GAA 3782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.